These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8516559)

  • 1. Efficient immunoselection of cytolytic effectors with a magnetic cell sorter.
    Jacobs N; Moutschen MP; Boniver J; Greimers R; Schaaf-Lafontaine N
    Res Immunol; 1993 Feb; 144(2):141-50. PubMed ID: 8516559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb.
    Jacobs N; Greimers R; Mazzoni A; Trebak M; Schaaf-Lafontaine N; Boniver J; Moutschen MP
    Cancer Immunol Immunother; 1996 Jul; 42(6):369-75. PubMed ID: 8830741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
    Stanková J; Hoskin DW; Roder JC
    Cell Immunol; 1989 Jun; 121(1):13-29. PubMed ID: 2470516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
    Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
    Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs IL2: disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity.
    Stohl W; Elliott JE
    Clin Immunol Immunopathol; 1992 Oct; 65(1):30-8. PubMed ID: 1395122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
    Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
    J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation.
    Jacobs N; Mazzoni A; Mezzanzanica D; Negri DR; Valota O; Colnaghi MI; Moutschen MP; Boniver J; Canevari S
    Cancer Immunol Immunother; 1997 Jul; 44(5):257-64. PubMed ID: 9247560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic effector function is present in resting peripheral T lymphocytes.
    Geisberg M; Dupont B
    Int Immunol; 1992 Nov; 4(11):1273-81. PubMed ID: 1472478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients.
    Tani M; Tanimura H; Yamaue H; Mizobata S; Iwahashi M; Tsunoda T; Noguchi K; Tamai M; Hotta T; Terasawa H
    Int J Cancer; 1995 Mar; 60(6):802-7. PubMed ID: 7896449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
    De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
    Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
    Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
    Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy.
    Lamers CH; van de Griend RJ; Braakman E; Ronteltap CP; Bénard J; Stoter G; Gratama JW; Bolhuis RL
    Int J Cancer; 1992 Jul; 51(6):973-9. PubMed ID: 1386349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies.
    Flens MJ; Mulder WM; Bril H; von Blomberg van de Flier MB; Scheper RJ; van Lier RA
    Cancer Immunol Immunother; 1993 Oct; 37(5):323-8. PubMed ID: 8402736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells.
    Flieger D; Kufer P; Beier I; Sauerbruch T; Schmidt-Wolf IG
    Cancer Immunol Immunother; 2000 Oct; 49(8):441-8. PubMed ID: 11043851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells.
    Ting CC; Hargrove ME
    Cell Immunol; 1992 Mar; 140(1):130-44. PubMed ID: 1531452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
    Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.